Hydrogels for precise biological and medical applications

CellDrop Bioengineers hydrogel platforms for precise control of chemical and biological systems
learn more

Faster, more durable tissue regeneration for equine athletes

CellDrop Bio is supporting Veterinarians through development of biotherapeutics to heal equine musculoskeletal injuries faster and reduce the chance of re-injury.

Learn More
Leveraging the power of hydrogel

Hydrogel microengineering is central to both biotherapeutic and rapid testing technologies.

view technology

learn More ➔

learn More ➔

Latest project news

January 3, 2023
CellDrop Biosciences raises seed round to advance promising new biologic

This seed round complements state and federal grant funding to advance CellDrop's hydrogel encapsulated allogeneic cell therapy, reducing it's time to market.

learn more
November 30, 2022
CellDrop Biosciences Submits Phase II National Science Foundation STTR

Successful completion of CellDrop's Phase I NSF STTR yielded promising results demonstrating safety and improved efficacy of their encapsulated therapy in a rodent model of tendon injury. To build on this success, they have submitted a Phase II NSF STTR funding a preclinical trial of their flagship therapeutic in equine superficial digital flexor tendon injuries.

learn more
January 10, 2022
CellDrop Biosciences Inc. to develop sensitive and extremely fast antigen tests

There remains an unmet need for accurate, inexpensive, point of care testing. To meet this need, CellDrop is developing rapid lateral flow assays for both COVID-19 and a variety of other antigens, using our hydrogel microengineering technology.

learn more
June 1, 2021
CellDrop Biosciences Inc. has been awarded a National Science Foundation (NSF) Small Business Technology Transfer (STTR) grant

This Phase I STTR Project will address the problem of suspensory ligament and superficial digital flexor tendon injuries in performance horses by developing an efficacy enhanced stem cell biotherapeutic.

learn more